Evidence map›Paper›PMID 35320895›Full record

ArticleKorean journal of family medicine2022

Primary Dysmenorrhea: Pathophysiology, Diagnosis, and Treatment Updates.

Rania Itani, Lama Soubra, Samar Karout, Deema Rahme, Lina Karout, Hani M J Khojah

5 registry-linked trialsOpen access · diamondAbstract read
In one paragraph

Article in Korean journal of family medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 5 registered trials, which are not on this map. Cited by 110 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 7 pooled it
42.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06146569 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Transcutaneous Vagus Nerve Stimulation (taVNS) in Individuals With Primary Dysmenorrhea: A Randomized Controlled Study

TypeinterventionalSponsorArtvin Coruh UniversityRan2023 to 2024Enrolled50ConditionsDysmenorrhea Primary, PainArmsTranscutaneous Auricular Vagus Nerve Stimulation (taVNS), Sham Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
NCT06227676 phase2 / phase3completednot on this map

Formative Assessment of the Effect of 'Cramp Bites' Intake on Primary Dysmenorrhea in Women Aged 18-25: A Placebo-Controlled Trial

TypeinterventionalSponsorCornell UniversityRan2022 to 2022Enrolled12ConditionsDysmenorrhea Primary, Dysmenorrhea, Menstrual Discomfort, Menstrual ProblemArmsCramp Bites by Aunt Flo's Kitchen
NCT06460870 naunknown statusnot on this mapstarted 2024, after this paper: background citation

Effect of Mojzisova Method on Pain, Menstrual Symptom and Insomnia in Primary Dysmenorrhea

TypeinterventionalSponsorRiphah International UniversityRan2024 to 2024Enrolled26ConditionsPrimary DysmenorrheaArmsMojzisova method, Stretching exercises
NCT06804473 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Effect of Aerobic Exercise on Clinical Symptoms During the Ovarian Cycle

TypeinterventionalSponsorUniversidad Francisco de VitoriaRan2025 to 2025Enrolled44ConditionsPrimary DysmenorrheaArmsExercise
NCT07052500 nacompletednot on this mapstarted 2025, after this paper: background citation

Investigating the Impact of Seed Cycling on Menstrual Regularity, Dysmenorrhea, and Premenstrual Symptoms

TypeinterventionalSponsorLoma Linda UniversityRan2025 to 2026Enrolled20ConditionsMenstruation Disorders, Menstrual Cramps, MenstruationArmsSeed Cycling
3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 7 syntheses or guidelines pooled it, 233 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pharmacological insights intoFrontiers in pharmacology · 2025
    Pooled it
  4. Pooled it
  5. Quality of patient-reported outcome measures for primary dysmenorrhea: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. An Examination into the Safety and Efficacy of KhapregesicInternational journal of women's health · 2025
    Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Rania ItaniPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Lama SoubraPharmacology and Therapeutics Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Samar KaroutPharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Deema RahmePharmacy Practice Department, Faculty of Pharmacy, Beirut Arab University, Beirut, Lebanon.
Lina KaroutDepartment of Radiology, American University of Beirut Medical Center, Beirut, Lebanon.
Hani M J KhojahDepartment of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University, Madinah, Kingdom of Saudi Arabia.
Beirut Arab University · LBAmerican University of Beirut Medical Center · LBTaibah University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary dysmenorrhea (PD) is a common, disregarded, underdiagnosed, and inadequately treated complaint of both young and adult females. It is characterized by painful cramps in the lower abdomen, which start shortly before or at the onset of menses and which could last for 3 days. In particular, PD negatively impacts the quality of life (QOL) of young females and is the main reason behind their absenteeism from school or work. It is suggested that increased intrauterine secretion of prostaglandins F2α and E2 are responsible for the pelvic pain associated with this disorder. Its associated symptoms are physical and/or psychological. Its physical symptoms include headache, lethargy, sleep disturbances, tender breasts, various body pains, disturbed appetite, nausea, vomiting, constipation or diarrhea, and increased urination, whereas its psychological symptoms include mood disturbances, such as anxiety, depression, and irritability. While its diagnosis is based on patients' history, symptoms, and physical examination, its treatment aims to improve the QOL through the administration of nonsteroidal anti-inflammatory drugs, hormonal contraceptives, and/or the use of non-pharmacological aids (e.g., topical heat application and exercise). Patients must be monitored to measure their response to treatment, assess their adherence, observe potential side effects, and perform further investigations, if needed.

Indexed as

Combined Oral ContraceptivesDiagnosisDysmenorrheaNon-Steroidal Anti-Inflammatory AgentsReviewTherapeutics

Identifiers

PMID35320895
PMCPMC8943241
OpenAlexW4220835311

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.